Table 3 The relation between FAP expression and clinicopathological characteristics
Variables | FAP expression | x2 | p value | |
|---|---|---|---|---|
Low n= 45 (62.5) | High n= 27 (37.5) | |||
Age | ||||
 <60 | 14 (66.7) | 7 (33.3) | 0.220 | 0.790 |
 ≥60 | 31 (60.8) | 20 (392) |  |  |
Gender | ||||
 Male | 24 (54.5) | 20 (45.5) | 3.055 | 0.081 |
 Female | 21 (75) | 7 (25) |  |  |
Tumor grade | ||||
 Low | 18 (72) | 7 (28) | 1.475 | 0.308 |
 High | 27 (57.4) | 20 (42.6) |  |  |
T-Primary tumor | ||||
 pTa | 17 (85) | 3 (15) |  |  |
 pT1 | 19 (76) | 6 (24) | 16.345 | 0.001* |
 pT2a | 5 (38.5) | 8 (61.5) |  |  |
 pT2b | 4 (28.6) | 10 (71.4) |  |  |
Associated Tis | ||||
 Absent | 26 (60.5) | 17 (39.5) | 0.189 | 0.805 |
 Present | 19 (65.5) | 10 (34.5) |  |  |
LVI | ||||
 Absent | 29 (74.4) | 10 (25.6) | 5.106 | 0.030* |
 Present | 16 (48.5) | 17 (51.5) |  |  |
N-Regional lymph nodes | ||||
 N0 | 9 (75) | 3 (25) |  |  |
 N1 | 3 (30) | 7 (70) | 6.372 | 0.041* |
 N2 | 1 (20) | 4 (80) |  |  |
M - Distant metastasis | ||||
 M0 | 19 (82.6) | 4 (17.4) | 11.152 | 0.004* |
 M1 | 0 (0) | 4 (100) |  |  |